BSX-BOSTON SCIENTIFIC CORP

Boston Scientific Surges 60.4% Over Last Year, Earns 'Strong Buy' Rating Amid Record Performance and Positive Earnings Outlook

Member Only Article

Friday

21 February, 2025

Boston Scientific has achieved an impressive 60.4% increase in share price over the past year, outpacing the industry significantly. With strong revenue growth and a bullish earnings outlook, can this medical device leader maintain its momentum in a challenging market?

article image for BSX

Article Impact Score

0
50
100
Under­perform
Bear­ish
Neu­tral
Bull­ish
Out­perform
0
Key Takeaways
  • Loading...

Most Read

Join Foliko Premium!

Unlock the entire library of Foliko's Generative AI Investment Research. Plus, get AI powered trading signals and stock price predictions.

Go Premium - 7 Day Free Trial
home-footer-logo

Any content provided on our website is for information purposes only. We do not provide investment advice, nor do we consider ourselves a financial institution. Seek a duly licensed professional for investment advice.